Table 3 Beta cell function (measured with HOMA Model Assessment [19], and T2DM risk measured with the risk score developed by Stern et al. [21] and prevalence of the metabolic syndrome (according to ATPIII criteria [20] in NGT and subjects with prediabetes diagnosed with the OGTT and HbA1c

From: Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population